Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias
Krikler, D.M.
Progress in Clinical and Biological Research 275: 301-317
1988
ISSN/ISBN: 0361-7742 PMID: 2902640 Document Number: 311930
Document emailed within 1 workday
Related Documents
Schneider, W.; Kaltenback, M. 1988: The use of beta-blockers in unstable angina: comparison with calcium channel blocking agents Journal of Cardiovascular Pharmacology 12(Suppl 1): S78-S82Pentel, P.R.; Salerno, D.M. 1990: Cardiac drug toxicity: digitalis glycosides and calcium-channel and beta-blocking agents Medical Journal of Australia 152(2): 88-94
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Birx, D.L.; Berger, M.; Fleisher, T.A. 1984: The interference of T cell activation by calcium channel blocking agents Journal of Immunology 133(6): 2904-2909
Nakaya, H.; Kanno, M.; Kanda, K.; Oyama, Y. 1980: Electrophysiologic effects of calcium channel blocking agents on the sinus node function in anesthetized dogs Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(8): 697-707
Chah, Q.T.; Bertrix, L.; Bouzouita, K.; Lang, J.; Faucon, G. 1983: Study of the ventricular antifibrillatory effects of calcium channel blocking agents in comparison with lidocaine on canine normal heart in situ Archives Internationales de Pharmacodynamie et de Therapie 261(2): 238-248
Bellomo, G.; Santucci, S.; Murrone, A.; Santambrogio, L.; Gennari, M.; Stangoni, G. 1988: Effects of calcium antagonists and beta-adrenergic receptor blocking agents on cardiovascular rhythmicity Panminerva Medica 30(4): 236-239
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Duan, H.J.; Fang, H.J.; Zhou, T.H.; Chen, C. 1991: Studies on the analysis of beta-blocking agents Yao Xue Xue Bao 26(5): 351-357
Serratrice, G.; Godde, J.L.; Schiano, A. 1977: Treatment of erythromelalgia with beta-blocking agents La Nouvelle Presse Medicale 6(42): 3973
Jackson, E.A.; Sullman, S.A. 1984: Comparative review of beta-blocking agents Connecticut Medicine 48(4): 213-215
Torsti, P. 1980: Use of beta blocking agents after myocardial infarction Duodecim; Laaketieteellinen Aikakauskirja 96(4): 282-283
Temkin, L.P. 1980: Calcium blocking agents. new directions in the treatment of angina pectoris Arizona Medicine 37(5): 328-333
Colace, F. 1970: Pharmacology and clinical use of adrenergic beta-blocking agents Il Policlinico. Sezione Pratica 77(20): 645-656
Conway, J. 1980: The antihypertensive action of beta-adrenoceptor blocking agents Archives Internationales de Pharmacodynamie et de Therapie Suppl: 83-91
Canale, J.M.; Horwitz, S. 1979: Therapeutic scope of beta-adrenergic blocking agents Archivos de Investigacion Medica 10(4): 261-277
Abinader, E.G. 1975: Auscultatory changes following ventricular extrasystoles and beta-blocking agents Irish Medical Journal 68(15): 369-375
Guilmot, J.L.; Perrotin, D.; Constans, T.; Pasticier, A. 1984: Peripheral vascular complications of beta-blocking agents Journal des Maladies Vasculaires 9(1): 59-62
Leary, W.P.; Morris, M.; Asmal, A.C. 1979: Effect of beta-blocking agents on renal function South African Medical Journal 56(19): 745
Kather, H.; Simon, B. 1977: Beta-blocking agents and human fat cell adenylate cyclase Research Communications in Chemical Pathology and Pharmacology 18(1): 11-22